Duality Biologics

Developer of ADC therapeutics to treat cancer and autoimmune diseases

placePudong, Shanghai, China calendar_todayFounded 2020 language dualitybiologics.com

Innovation

37 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 766 times.

YearFilings
20223
202311
202415
202530
20265

Social engagement

Social engagement: 7.9K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include WuXi Biologics, 6 Dimensions Capital, LAV Asset Management.

Investor typeCountShare
Venture capital457%
Private equity229%
Other / undisclosed114%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

20 May 2026 · Associate Director Portfolio Management · Shanghai

Based on job postings tracked across public sources.

Coming soon